First patient receives partial epigenetic reprogramming for glaucoma
In June, a patient in the United States became the first person to receive ER 100, an experimental therapy that uses partial epigenetic reprogramming. The treatment is being tested for age-related optic…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.